[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-336278-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-336278-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","tubb-a-robust-biomarker-with-satisfying-abilities-in-diagnosis-prognosis-and-immune-regulation-via-a-comprehensive-pan-cancer-analysis","TUBB - a robust biomarker with satisfying abilities in diagnosis, prognosis, and immune regulation via a comprehensive pan-cancer analysis","","TUBB is investigated as a beta-tubulin encoding biomarker whose role across cancers remains unclear. Integrative pan-cancer analyses leverage multiple public datasets (TCGA and other resources) to evaluate diagnostic and prognostic potential from several angles, including differential expression, mutations, copy number alterations, and DNA methylation. GSEA and survival profiling characterize associated biological functions and outcomes, while cMAP is used to explore drugs or micro-molecules influencing TUBB expression. Results indicate early-diagnostic value, links to clinical features, metabolism/metastasis/immune pathways, and correlations with lymphocyte-infiltration immune regulators.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/tubb-a-robust-biomarker-with-satisfying-abilities-in-diagnosis-prognosis-and-immune-regulation-via-a-comprehensive-pan-cancer-analysis/336278/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/tubb-a-robust-biomarker-with-satisfying-abilities-in-diagnosis-prognosis-and-immune-regulation-via-a-comprehensive-pan-cancer-analysis/336278.png","ImageObject",300,407,{"name":42,"@type":43},"Eliana","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-27","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main purpose of analyzing TUBB in this study?","Question",{"text":63,"@type":64},"To explore the value of TUBB in cancer diagnosis, prognosis, and immune function by performing systematic pan-cancer analyses.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which data and analytical approaches were used to study TUBB?",{"text":68,"@type":64},"The study collected integrative data from multiple public cancer databases and performed diagnostic/prognostic evaluations, GSEA for biological functions, survival profiling, molecular subtype comparisons, and cMAP-based search for drugs or micro-molecules affecting TUBB expression.",{"name":70,"@type":61,"acceptedAnswer":71},"What were the key findings regarding TUBB expression and cancer outcomes?",{"text":72,"@type":64},"TUBB showed differential expression across tumor types with early-diagnostic value, abnormal expression linked to genomic/epigenetic changes, associations with clinical features, and significant correlations with metabolism, metastasis, and immune pathways as well as prognosis and immune regulation markers.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},336278,1790269344,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":117,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":104,"preview_page_count":33,"preview_urls":144},4398048949847,"https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267","TYPE Original Research PUBLISHED 02 May 2024  \nDOI 10.3389/fmolb.2024.1365655  \nOPEN ACCESS  \nEDITED BY  \nYi Chieh Lim,  \nDanish Cancer Society Research Center (DCRC), Denmark  \nREVIEWED BY  \nRajeev Nema,  \nManipal University Jaipur, India Hassan Dastsooz,  \nUniversity of Turin, Italy  \n*CORRESPONDENCE  \nYing Zhang,  \n [zy1122812@163.com](zy1122812@163.com)[ ](zy1122812@163.com)Xi Cao,  \n [caoxi@ahmu.edu.cn](caoxi@ahmu.edu.cn)  \n†These authors have contributed equally to this work and share ﬁrst authorship  \nRECEIVED 04 January 2024  \nACCEPTED 12 April 2024  \nPUBLISHED 02 May 2024  \nCITATION  \nZhu Z, Zhang W, Huo S, Huang T, Cao X and Zhang Y (2024), TUBB, a robust biomarker with satisfying abilities in diagnosis, prognosis, and immune regulation via a comprehensive pancancer analysis.  \nFront. Mol. Biosci. 11:1365655 .  \ndoi: 10.3389/fmolb.2024.1365655  \nCOPYRIGHT  \n© 2024 Zhu, Zhang, Huo, Huang, Cao and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nTUBB, a robust biomarker with satisfying abilities in diagnosis, prognosis, and immune regulation via a comprehensive pan-cancer analysis  \nZaifu Zhu 1†, Wei Zhang 2†, Shaohu Huo 1, Tiantuo Huang 1, Xi Cao 3,4* and Ying Zhang 5, 6*  \n1Department of Pediatrics, First Afﬁliated Hospital of Anhui Medical University, Hefei, Anhui, China, 2Department of Rehabilitation Medicine, First Afﬁliated Hospital of Anhui Medical University, Hefei, Anhui, China, 3Department of Pharmacy, First Afﬁliated Hospital of Anhui Medical University, Hefei, Anhui, China, 4The Grade 3 Pharmaceutical Chemistry Laboratory of State Administration of Traditional Chinese Medicine, Hefei, Anhui, China, 5Department of Pathology, First Afﬁliated Hospital of Anhui Medical University, Hefei, Anhui, China, 6Pathology Center, Anhui Medical University, Hefei, Anhui, China  \nPurpose: TUBB can encode a beta-tubulin protein. At present, the role of TUBB has not been ascertained in cancers. Hence, the importance of further systematic pan-cancer analyses is stressed to explore its value in the diagnosis, prognosis, and immune function of cancers.  \nMethods: By collecting and handling integrative data from the TCGA, Firehose, UCSC Xena, cBioPortal, GEO, CPTAC, TIMER2.0, TISCH, CellMiner, GDSC, and CTRP databases, we explored the potential diagnostic and prognostic roles of TUBB in pan-cancers from multiple angles. Moreover, the GSEA analysis was conducted to excavate the biological functions of TUBB in pan-cancers. In addition, survival proﬁles were described, and the differential expressions of TUBB in different molecular subtypes were discussed. Also, we utilized the cMAP function to search drugs or micro-molecules that have an impact on TUBB expressions.  \nResults: Based on the TCGA data, we found that TUBB was differentially expressed in a variety of tumors and showed an early-diagnostic value. Mutations, somatic copy number alterations, and DNA methylation would lead to its abnormal expression. TUBB expressions had relations with many clinical features. What’s more, TUBB expressions were validated to be related to many metabolism-related, metastasis-related, and immune-related pathways. High TUBB expressions were proved to have a great impact on the prognosis of various types of cancers and would affect the sensitivity of some drugs. We also demonstrated that the expression of TUBB was signiﬁcantly correlated to immunoregulator molecules and biomarkers of lymphocyte subpopulation inﬁltration.  \nConclusion: TUBB and its regulatory genes were systemically analyzed in this study, showing that TUBB had satisfying perform","cbCaif3rhx8hAZeE","https://ap.wps.com/l/cbCaif3rhx8hAZeE","pdf",11226135,"English","# Purpose\n# Methods\n# Results\n# Conclusion\n# Introduction\n## Background on cancer therapies and biomarkers\n## Rationale for pan-cancer analysis of TUBB","[{\"question\":\"What is the main purpose of analyzing TUBB in this study?\",\"answer\":\"To explore the value of TUBB in cancer diagnosis, prognosis, and immune function by performing systematic pan-cancer analyses.\"},{\"question\":\"Which data and analytical approaches were used to study TUBB?\",\"answer\":\"The study collected integrative data from multiple public cancer databases and performed diagnostic/prognostic evaluations, GSEA for biological functions, survival profiling, molecular subtype comparisons, and cMAP-based search for drugs or micro-molecules affecting TUBB expression.\"},{\"question\":\"What were the key findings regarding TUBB expression and cancer outcomes?\",\"answer\":\"TUBB showed differential expression across tumor types with early-diagnostic value, abnormal expression linked to genomic/epigenetic changes, associations with clinical features, and significant correlations with metabolism, metastasis, and immune pathways as well as prognosis and immune regulation markers.\"}]","TUBB - a robust biomarker with satisfying abilities in diagnosis, prognosis, and immune regulation via a comprehensive pan-cancer analysis | PDF",1790014381,[145,149,153,157],{"page_no":22,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c70f7ac2dc499e80c7173a241d41bb05.webp",983,1390,{"page_no":26,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b8d4bd3fe3d6be3c33624f18e2773b3b.webp",982,1388,{"page_no":30,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/928158e959a3a80a217b5c171513b819.webp",981,1387,{"page_no":33,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9f5da062b193edb3e1068fab751f0c22.webp",980,1385]